AstraZeneca buying drug developer in £30bn deal
Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.
Full Article
AstraZeneca buying drug developer in £30bn deal
Belfast Telegraph
0 shares
1 views
You might like
Related news coverage
Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
SeattlePI.com
NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday:
Alexion Pharmaceuticals Inc., up $35.33 to..
-
Vaccine developer AstraZeneca buys US drug company for 39 billion dollars
Belfast Telegraph
-
AstraZeneca buying drug developer Alexion for $39 billion
SeattlePI.com